Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04488913 · ClinicalTrials.gov registry record · NA
Rapid Acute Coronary Syndrome Exclusion Using High-sensitivity I Troponin
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 32,609
- Enrollment target
NCT04488913 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 32,609 participants.
The verdict
NCT04488913, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 32,609 participants
- Enrollment target
Study Summary
As part of the planned implementation of a new clinical pathway using hs-cTnI, the investigators will measure patient outcomes and clinical processes in a real-world scenario throughout an integrated health system across 9 emergency departments (ED).
Interventions
- OTHER Standard of Care
- OTHER RACE-IT Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32,609 participants |
| Start Date | 2020-07-29 |
| Est. Completion | 2022-03-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04488913
The ClinicalTrials.gov registry entry for NCT04488913 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32,609 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04488913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04488913 about?
NCT04488913 is a clinical study titled "Rapid Acute Coronary Syndrome Exclusion Using High-sensitivity I Troponin". As part of the planned implementation of a new clinical pathway using hs-cTnI, the investigators will measure patient outcomes and clinical processes in a real-world scenario throughout an integrated health system across 9 emergency departments (ED).
What is the current status of trial NCT04488913?
This trial is currently completed. It is a NA study. The enrollment target is 32,609 participants. The study started on 2020-07-29. Estimated completion is 2022-03-03.
What interventions are being tested in trial NCT04488913?
The interventions under investigation include: Standard of Care (OTHER), RACE-IT Pathway (OTHER).
Who is sponsoring clinical trial NCT04488913?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.